期刊论文详细信息
Frontiers in Oncology 卷:12
Identification of Immune-Related Breast Cancer Chemotherapy Resistance Genes via Bioinformatics Approaches
Yabing Du1  Wang Ma1  Yikai Han1  Huanrong Wang1  Kaiyuan Guo1  Xin Wang2  Lijun Fu3  Yanhong Qu4 
[1] Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;
[2] Department of Radiotherapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;
[3] Department of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;
[4] Oncology Department of Laiyang People’s Hospital, Laiyang, China;
关键词: breast cancer;    chemotherapy resistance;    immune microenvironment;    PRC1;    GGTLC1;    IRS1;   
DOI  :  10.3389/fonc.2022.772723
来源: DOAJ
【 摘 要 】

Chemotherapy resistance in breast cancer is an important factor affecting the prognosis of breast cancer patients. We computationally analyzed the differences in gene expression before and after chemotherapy in breast cancer patients, drug-sensitive groups, and drug-resistant groups. Through functional enrichment analysis, immune microenvironment analysis, and other computational analysis methods, we identified PRC1, GGTLC1, and IRS1 as genes that may mediate breast cancer chemoresistance through the immune pathway. After validation of certain other clinical datasets and in vitro cellular assays, we found that the above three genes influenced drug resistance in breast cancer patients and were closely related to the tumor immune microenvironment. Our finding that chemoresistance in breast cancer could be influenced by the mediation of tumor immunity expanded our knowledge of how to address this problem and could guide future research involving chemoresistance.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:2次